KNCV Publications 2026

Deyanova N, McQuaid CF, Kochanov V, Bogdanov A, Madden N, Charalambous S, van Kalmthout K, Jerene D, Fielding KL, Gamazina K. The effects of war on digital adherence technology engagement for TB treatment in Ukraine. IJTLD Open. Jan 9, 2026.
Olabamiji JO, Ochei K, Daniel O, Eneogu R, lhesie A, Nongo D, Agbaje A, Dakum P, Elom E, Mwansasu A, Colvin C, Diaz N, Adelekan A, Oyelaran S, Mensah C, Odola O, Olayemi A, de Haas P, Klinkenberg E. Evaluation of stool-based testing to diagnose tuberculosis in children using the Truenat platform in routine settings in Nigeria. J Clin Microbial. Jan 14, 2026.
de Haas P, Kabugo J, Namutebi J, Tie me rs ma E, Ssentamu Nakato H, Manyonge C, Kisakye D, Atwine Mukama T, Nassozi D, Mwansasu A, Joloba M, Klinkenberg E. Evaluation of the Simple One-Step (SOS) stool method for Truenat MTB plus and Xpert MTB/XDR assay. J Clin Microbial. Jan 14, 2026.
Tunje A, Lundqvist P, Persson MC, Kristjansd6ttir G, Vilhjalmsson R, Jerene D. Economic evaluation of digital health interventions to improve quality-adjusted life years in adolescents living with HIV in Ethiopia. Front Public Health. Jan 23, 2026.
Chukwuogo 0, Odume B, Ugochukwu L, Ogbudebe C, Chukwu E, Useni S, Nwokoye N, Sheshi M, Nongo D, lhesie A, Eneogu R, Ubochioma E. Routine active case finding in Nigerian penitentiary institutions: comparing yields from digital X-ray with CAD4TB and WHO 4-symptom screening. BMC Infect Dis. Jan 27, 2026.
Haverkate TMI, Brais D, Abukaraig EAB Kapata N, Kapata-Chanda P, Kirenga B, Klinkenberg E, Law I, Maama-Maime LB, Moyo S, Obasanya J, Rutebemberwa E, Stuck L, Tiemersma E, Cobelens F. Environmental-demographic determinants associated with tuberculosis prevalence in seven African countries: an aggregated dataset analysis. EClinicalMedicine. Jan 28, 2026.
Tanvir H, Clark RA, SumnerT, Horton KC, Prys-Jones TO, Bakker R, Rade K, Mave V, Hatherill M, Churchyard GJ, Houben RMGJ, White RG. Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling study. PLoS Med. Feb 12, 2026.
Ahmad R, Ramos JP, Duarte R, Lange C, Van Rest J. Enhancing tuberculosis care in lower and middle-income countries through digital adherence technologies. Breathe {Sheff). Feb 17, 2026.
Wakjira MK, Jerene D, Dano DH, Datiko DG, Adugna MA, Abagaro TA, De me mew ZG, Alemayehu YM, Memberu HW, Mohammed JS, Ahmed OA, Woldegiorgis AG, Oli GF, Binagde DN, Kassa AA. Providing comprehensive TB care among conflict-affected populations. lntJ Tuberc Lung Dis. Feb 27, 2026.
Issufo, S, Mavume-Mangunyane, E, Valverde, E, Ndima S, Chimoyi L, Penicela C, Andrade I, Berthilde U, Botao C, Malate PG, Bruno CC, Nhangave A, Goncalves-Tasca B, Madden N, Powers R, Mulder C, Keller S, Roland Peregrino R, Spruijt I. Feasibility and acceptability of COVID-19 self-testing offered through community screening posts in Mozambique: a mixed-methods study. BMC Public Health 26, 1203. March 06, 2026.
Jaganath D, Nabeta P, Nicol MP, Castro R, Wambi P, Zar HJ, Workman L, Lodha R, Singh UB, Bavdekar A, Sanghavi S, Trollip A, Mace A, Bonnet M, Lounnas M, de Haas P, Tiemersma E, Alland D, Banada P, Cattamanchi A, Ruhwald M, Wobudeya E, Denkinger CM; Stool H2H Study Team. Stool Processing Methods for Xpert Ultra Testing in Childhood Tuberculosis: A Prospective, Multicountry Accuracy Study. Clin Infect Dis. March 17, 2026.
Moe CA, Barua S, Vijayan S, Andama AO, Bimba J, Christopher DJ, Dinh VL, Phan H, Theron G, Worodria W, Yu C, Kremer K, Nahid P, Yerlikaya S, Denkinger CM, Cattamanchi A, Muyoyeta M. Impact of sputum quality on Xpert MTB/RIF Ultra test results for tuberculosis: A multi-country study. medRxiv [Preprint]. April 3, 2026.
Salles I, Lessem E, Walshe L, Myrzaliev B, Hoa NB, Shah M, Chaisson RE, Manabe YC. Stakeholder engagement to identify barriers to implementation and inform the development of point-of-care diagnostics for TB. IJTLD Open. Apr 13, 2026. eCollection 2026 Apr.
Flores I, Tujan MAA, Basilio R, Dizon TJR, Lim DR, Reyes LT, Reyes RVAG, Rojas S, Valencia AK, Capin JB, Mirtskhulava V, Palparan AG, Cabalitan C, Carpin PJ, Malbacias C, Lee JS, Gebhard A, Quelapio M, Timm J. High efficacy of BPaL among patients infected with Mycobacterium tuberculosis lineage 1 in the Philippines. IJTLD Open. Apr 13, 2026. eCollection 2026 Apr.
Savic M, Theron G, Bobosha K, Nyombi BM, Laake I, Josifoski A, Arsov J, Assefa T, Bikombo J, Borain N, Davchev J, Grunwald S, Habtesilase YA, Kajeguka DC, Kremer K, Mayo F, Medina-Marino A, Najdov S, Okunola AO, Ndaro AJ, Nwamba WV, Olomi GA, du Plessis J, Semvua HH, Welsink T, Wondiyfraw M, Yeshambaw M, Yesuf SA, Yimer SA, Holm-Hansen CC. Feasibility, accuracy, and effect of a rapid point-of-care serological test (SeroSelectTB) to identify presumptive pulmonary TB patients for confirmatory testing in Ethiopia, South Africa, and Tanzania: a multicenter, open-label, parallel-group, randomized, controlled trial. EClinicalMedicine. April 25, 2026. eCollection 2026 May.
Ajide B, Moe CA, Barrameda J, Chirwa M, Rockman L, de Haas P, de Vos M, Kato-Maeda M, Tasca B, Bimba J, Yu C, Denkinger CM, Kremer K, Nahid P, Cattamanchi A, Theron G, Muyoyeta M. Tongue swab Xpert MTB/RIF Ultra testing for TB using a revised consensus protocol. Int J Tuberc Lung Dis. Apr 27, 2026.
Yerlikaya S, Chirwa M, Ajide B, Castro MDM, Ha H, Kato-Maeda M, Kisakye E, Marcelo D, Mochizuki T, Rockman L, Steadman A, Thangakunam B, Bimba JS, Christopher DJ, Muyoyeta M, Phan H, Theron G, Yu C, Kremer K, Phillips PPJ, Nahid P, Denkinger CM, Cattamanchi A, Andama A; Pulmonary Tuberculosis Detection with MiniDock MTB Using Swab Samples. R2D2 TB Network and SMART4TB Consortia. N Engl J Med. April 30, 2026.
de Vos M, Le H, Marcelo D, Ajide B, Alí-Francia KG, Borkman AL, Desravines R, Chang HT, Dowling W, Kamulegeya L, Marconi S, Moe CA, Rockman L, Shuma B, Christopher DJ, Hapeela N, Muyoyeta M, Nakiyingi L, Theron G, Ugarte-Gil C, Hung NV, Luong DV, Yu C, Alland D, Denkinger CM, Ellner J, Dorman SE, Kremer K, Manabe YC, Nahid P, Ruhwald M, Shah M, Penn-Nicholson A, Cattamanchi A, Bimba JS; Multicountry assessment of tongue swabs for tuberculosis using a common protocol for Xpert MTB/RIF Ultra testing: a prospective diagnostic accuracy study. FEND-TB, R2D2 TB Network, and SMART4TB/ADAPT Consortia. Lancet Microbe. June, 2026. Epub May 15, 2026.
Chihota V, Waggie Z, Cardenas V, Mngadi K, Ndebele F, Brumskine W, Sebe M, Martinson N, Wang SH, Yimer G, Nguenha D, Garcia-Basteiro AL, van den Hof S, Grant AD, Charalambous S, Fielding KL, Chaisson RE, Churchyard G. Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial. Clin Infect Dis. May 17, 2026 . Online ahead of print.
Achalu DL, Meshesha SG, Kiltu AB, Wendimu DE, Tegegne NA, Alemu A, Tiemersma EW, Cobelens F, Teferi M. Performance of active drug safety monitoring and management for pharmacovigilance strengthening in Ethiopia, experience from a multidrug-resistant tuberculosis management program: a cross-sectional study. BMJ Open. May 20, 2026.
Ukai T, Thu KS, Uchimura K, Ohkado A, Yoshiyama T, Tiemersma E. Asymptomatic tuberculosis in Japan: a 15-year national surveillance study, 2008-2022. Lancet Reg Health West Pac. May 21, 2026. eCollection 2026 May.
Buis J, Pell C, Mungunda H, Nunurai R, Ogbudebe C, Odume B, Chijioke-Akaniro O, Letta Janfa T, Mamba BN, Leung CL, del Greco F, Fiekert K. Stakeholder perspectives on the people-centred framework in strategic planning for tuberculosis programmes: a cross-country qualitative study [PRE Print]. VeriXiv 2026.
Tsope L, Chimoyi L, Kennar A, Rabothata I, Sisay S, Sithole K, Kawaza N, Apollo T, Gwanzura C, Dressie S, Bedru A, Mulder C, et al. ‘Why should I start medication when I am not feeling sick?’ A qualitative study of refusal, initiation, completion and discontinuation of tuberculosis preventive treatment among people living with HIV in sub-Saharan Africa. BMJ Public Health. July 3, 2026.